Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd (SHE:301126)

SHE:301126 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021	Dec 31, 2020
Operating Revenue	5,367	5,220	3,894	3,279	2,586	2,335
Other Revenue	13.33	13.33	9.37	13.5	6.12	5.15
Revenue	5,380	5,233	3,904	3,292	2,592	2,340
Revenue Growth (YoY)	5.30%	34.07%	18.56%	27.01%	10.79%	-4.75%
Cost of Revenue	4,405	4,197	3,335	2,901	2,292	2,073
Gross Profit	975.7	1,036	568.05	391.68	300.35	266.32
Selling, General & Admin	789.23	821.41	421.39	254.61	148.43	132.68
Research & Development	14.25	16.26	7.17	0.52	-	-
Other Operating Expenses	-10.16	-6.21	1.97	11.58	10.13	8.91
Operating Expenses	803.51	839.34	445.44	283.46	172.06	145.76
Operating Income	172.19	196.75	122.61	108.23	128.3	120.56
Interest Expense	-112.61	-107.82	-69.51	-40.75	-34.89	-31.55
Interest & Investment Income	2.83	3.54	5.3	7.74	1.05	0.81
Other Non Operating Income (Expenses)	-5.68	-6.36	-9.25	-4.74	-2.68	-2.19
EBT Excluding Unusual Items	56.73	86.11	49.15	70.48	91.79	87.63
Impairment of Goodwill	-12.61	-12.61	-	-	-	-
Gain (Loss) on Sale of Investments	-0.38	-0.38	-0.15	-	-	-
Gain (Loss) on Sale of Assets	2.49	1.38	1.11	0.32	-	-0
Asset Writedown	-0.71	-0.06	-0.48	-0.01	-	-
Other Unusual Items	-0.77	1.55	-1.07	5.39	4.22	2.5
Pretax Income	44.74	76	48.55	76.17	96.01	90.13
Income Tax Expense	16.79	24.66	10.54	20.85	27.75	25.27
Earnings From Continuing Operations	27.96	51.33	38.01	55.32	68.26	64.85
Minority Interest in Earnings	-32.74	-24.76	-3.71	-4.25	-	-
Net Income	-4.78	26.57	34.3	51.08	68.26	64.85
Net Income to Common	-4.78	26.57	34.3	51.08	68.26	64.85
Net Income Growth	-	-22.52%	-32.85%	-25.17%	5.25%	-26.01%
Shares Outstanding (Basic)	205	204	202	204	155	154
Shares Outstanding (Diluted)	205	204	202	204	155	154
Shares Change (YoY)	0.33%	1.32%	-1.25%	31.70%	0.47%	0.41%
EPS (Basic)	-0.02	0.13	0.17	0.25	0.44	0.42
EPS (Diluted)	-0.02	0.13	0.17	0.25	0.44	0.42
EPS Growth	-	-23.53%	-32.00%	-43.18%	4.76%	-26.32%
Free Cash Flow	1.72	-163.1	-199.57	-702.69	-195.1	-197.41
Free Cash Flow Per Share	0.01	-0.80	-0.99	-3.44	-1.26	-1.28
Dividend Per Share	0.104	0.082	0.040	0.029	0.034	-
Dividend Growth	159.50%	104.50%	37.93%	-14.71%	-	-
Gross Margin	18.14%	19.80%	14.55%	11.90%	11.59%	11.38%
Operating Margin	3.20%	3.76%	3.14%	3.29%	4.95%	5.15%
Profit Margin	-0.09%	0.51%	0.88%	1.55%	2.63%	2.77%
Free Cash Flow Margin	0.03%	-3.12%	-5.11%	-21.34%	-7.53%	-8.44%
EBITDA	365.04	342.7	206.05	130.85	142.38	133.15
EBITDA Margin	6.78%	6.55%	5.28%	3.98%	5.49%	5.69%
D&A For EBITDA	192.85	145.96	83.44	22.63	14.08	12.59
EBIT	172.19	196.75	122.61	108.23	128.3	120.56
EBIT Margin	3.20%	3.76%	3.14%	3.29%	4.95%	5.15%
Effective Tax Rate	37.52%	32.46%	21.72%	27.37%	28.90%	28.04%
Revenue as Reported	5,380	5,233	3,904	3,292	2,592	2,340
Advertising Expenses	-	77.9	34.34	8.87	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.